260 related articles for article (PubMed ID: 30122648)
1. Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China.
Cui A; Zhu Z; Mao N; Si Y; Ma Y; Hu Y; Deng X; Wang L; Zeng L; Zhang Y; Xu W
Vaccine; 2018 Sep; 36(38):5725-5731. PubMed ID: 30122648
[TBL] [Abstract][Full Text] [Related]
2. Cross-neutralization between three mumps viruses & mapping of haemagglutinin-neuraminidase (HN) epitopes.
Vaidya SR; Dvivedi GM; Jadhav SM
Indian J Med Res; 2016 Jan; 143(1):37-42. PubMed ID: 26997012
[TBL] [Abstract][Full Text] [Related]
3. Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection.
Gouma S; Ten Hulscher HI; Schurink-van 't Klooster TM; de Melker HE; Boland GJ; Kaaijk P; van Els CACM; Koopmans MPG; van Binnendijk RS
Vaccine; 2016 Jul; 34(35):4166-4171. PubMed ID: 27372154
[TBL] [Abstract][Full Text] [Related]
4. Cross-neutralization between vaccine and circulating wild-type mumps viruses in Korea.
Won H; Kim AR; Yoo JS; Chung GT; Kang HJ; Kim SJ; Kim SS; Lee JW
Vaccine; 2021 Mar; 39(13):1870-1876. PubMed ID: 33642163
[TBL] [Abstract][Full Text] [Related]
5. Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies.
Šantak M; Lang-Balija M; Ivancic-Jelecki J; Košutić-Gulija T; Ljubin-Sternak S; Forcic D
Epidemiol Infect; 2013 Jun; 141(6):1298-309. PubMed ID: 22954346
[TBL] [Abstract][Full Text] [Related]
6. Sera from different age cohorts in Belgium show limited cross-neutralization between the mumps vaccine and outbreak strains.
Vermeire T; Barbezange C; Francart A; Hamouda A; Litzroth A; Hutse V; Martens L; Vandermarliere E; Van Gucht S
Clin Microbiol Infect; 2019 Jul; 25(7):907.e1-907.e6. PubMed ID: 30502489
[TBL] [Abstract][Full Text] [Related]
7. Identification and development of a promising novel mumps vaccine candidate strain.
Liang Y; Ma S; Liu L; Zhao H; Wang L; Jiang L; Xie Z; Dong C; Li Q
Microbes Infect; 2010 Dec; 12(14-15):1178-87. PubMed ID: 20800105
[TBL] [Abstract][Full Text] [Related]
8. Mumps Epidemiology and Mumps Virus Genotypes Circulating in Mainland China during 2013-2015.
Cui A; Zhu Z; Hu Y; Deng X; Sun Z; Zhang Y; Mao N; Xu S; Fang X; Gao H; Si Y; Lei Y; Zheng H; He J; Wu H; Xu W
PLoS One; 2017; 12(1):e0169561. PubMed ID: 28085897
[TBL] [Abstract][Full Text] [Related]
9. [Virus strain specific serum neutralizing antibodies in children and adolescents immunized with a Russian mumps vaccine].
Otrashevskaia EV; Krasil'nikov IV; Ignat'ev GM
Vopr Virusol; 2010; 55(6):15-9. PubMed ID: 21381334
[TBL] [Abstract][Full Text] [Related]
10. Assessment of mumps-containing vaccine effectiveness during an outbreak: Importance to introduce the 2-dose schedule for China.
Ma C; Liu Y; Tang J; Jia H; Qin W; Su Y; Wang H; Hao L
Hum Vaccin Immunother; 2018 Jun; 14(6):1392-1397. PubMed ID: 29377772
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation on the short term effectiveness of two doses mumps-containing vaccine policy in Shandong, China].
Xu Q; Xiong P; Fang XQ; Liu XD; Wang CY; Song LZ; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):265-270. PubMed ID: 29973005
[No Abstract] [Full Text] [Related]
12. [Functional state of specific immunity in children and teenagers vaccinated against mumps].
Otrashevskaia EV; Bukin EK; Krasil'nikov IV; Ignat'ev GM
Vopr Virusol; 2010; 55(4):20-5. PubMed ID: 20886708
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China.
Zengel J; Phan SI; Pickar A; Xu P; He B
Vaccine; 2017 Jul; 35(32):3988-3994. PubMed ID: 28623030
[TBL] [Abstract][Full Text] [Related]
14. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.
Rubin SA; Qi L; Audet SA; Sullivan B; Carbone KM; Bellini WJ; Rota PA; Sirota L; Beeler J
J Infect Dis; 2008 Aug; 198(4):508-15. PubMed ID: 18558869
[TBL] [Abstract][Full Text] [Related]
15. Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003.
Atrasheuskaya AV; Blatun EM; Kulak MV; Atrasheuskaya A; Karpov IA; Rubin S; Ignatyev GM
Vaccine; 2007 Jun; 25(24):4651-8. PubMed ID: 17498853
[TBL] [Abstract][Full Text] [Related]
16. Mumps outbreaks in a highly vaccinated population: Investigation of a neutralization titre against the current circulating wildtype genotype G5 mumps virus.
Kenny L; O'Kelly E; Connell J; De Gascun C; Hassan J
J Clin Virol; 2016 Jan; 74():8-12. PubMed ID: 26630067
[TBL] [Abstract][Full Text] [Related]
17. An efficient, reproducible and accurate RT-qPCR based method to determine mumps specific neutralizing antibody.
Sikazwe CT; Levy A; Speers D; Smith DW
J Virol Methods; 2020 Mar; 277():113817. PubMed ID: 31911119
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and Safety of an F-Genotype Attenuated Mumps Vaccine in Healthy 8- to 24-Month-Old Children.
Liang Y; Che Y; Yang B; Zhan F; Li H; Guan X; Zhang Y; Yin Q; Li C; Li J; Zhao Z; Liu L; Jiang G; Liao Y; Xu X; Ye J; Ren Q; He Y; Feng M; Wang L; Fan S; Cui X; Wang Z; Li C; Xiao H; Liu R; Li Q; Jiang C; Liu J; Li Q
J Infect Dis; 2019 Jan; 219(1):50-58. PubMed ID: 30085178
[TBL] [Abstract][Full Text] [Related]
19. Novel polyvalent live vaccine against varicella-zoster and mumps virus infections.
Matsuura M; Somboonthum P; Murakami K; Ota M; Shoji M; Kawabata K; Mizuguchi H; Gomi Y; Yamanishi K; Mori Y
Microbiol Immunol; 2013 Oct; 57(10):704-14. PubMed ID: 23905963
[TBL] [Abstract][Full Text] [Related]
20. Outbreak of mumps in a student population with high vaccination coverage in China: time for two-dose vaccination.
Qin W; Wang Y; Yang T; Xu XK; Meng XM; Zhao CJ; Li SY; Xie SY; Li KC; Su H
Hum Vaccin Immunother; 2019; 15(9):2106-2111. PubMed ID: 30779678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
